IRIS
ROTONDI, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.825
EU - Europa 2.625
AS - Asia 1.676
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
AF - Africa 3
Totale 8.139
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.817
CN - Cina 1.661
IE - Irlanda 1.013
UA - Ucraina 440
FI - Finlandia 348
DE - Germania 257
IT - Italia 191
SE - Svezia 141
GB - Regno Unito 126
FR - Francia 68
BE - Belgio 18
CA - Canada 8
NL - Olanda 8
EU - Europa 5
VN - Vietnam 4
BR - Brasile 3
RU - Federazione Russa 3
SG - Singapore 3
AT - Austria 2
BD - Bangladesh 2
CL - Cile 2
GR - Grecia 2
IL - Israele 2
JP - Giappone 2
LV - Lettonia 2
MU - Mauritius 2
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
KR - Corea 1
NG - Nigeria 1
RO - Romania 1
SI - Slovenia 1
TR - Turchia 1
Totale 8.139
Salva come PNG Salva come JPEG
Città #
Dublin 1.013
Chandler 971
Jacksonville 580
Nanjing 525
Ashburn 250
Princeton 208
Nanchang 202
Lawrence 199
Wilmington 170
Hebei 166
Shenyang 145
Changsha 140
Medford 138
Jiaxing 116
Beijing 114
Helsinki 85
Ann Arbor 73
Boardman 71
Hangzhou 65
Tianjin 65
Milan 50
New York 45
Woodbridge 45
Shanghai 43
Verona 34
Falls Church 33
San Genesio Ed Uniti 26
Norwalk 24
Seattle 20
Brussels 18
Fairfield 15
Auburn Hills 14
Pavia 13
Washington 13
Falkenstein 11
Kunming 11
Tappahannock 10
Ningbo 9
Rome 9
Guangzhou 8
Taizhou 8
Zhengzhou 8
Des Moines 7
Jinan 7
Orange 6
Toronto 6
Bologna 5
Buffalo 5
Genoa 5
Houston 5
Redwood City 5
Dong Ket 4
San Francisco 4
Carbonara al Ticino 3
Dearborn 3
Los Angeles 3
Quinzano d'Oglio 3
Strasbourg 3
São Paulo 3
Amsterdam 2
Arnold 2
Athens 2
Avellino 2
Cambridge 2
Changchun 2
Dhaka 2
Florence 2
Lanzhou 2
Las Vegas 2
Maastricht 2
Mariglianella 2
Mesero 2
Monza 2
Naples 2
Neviano degli Arduini 2
Ramat Gan 2
Rozzano 2
Singapore 2
Tokyo 2
Vienna 2
Abuja 1
Altavilla Vicentina 1
Ankara 1
Augusta 1
Berlin 1
Borås 1
Casalgrande 1
Fuzhou 1
Grossmuehlingen 1
Hefei 1
Ilford 1
Joliette 1
Leawood 1
Lecce 1
Littlehampton 1
Liverpool 1
Lucerne 1
Ludwigshafen Am Rhein 1
Lutzingen 1
Moncalieri 1
Totale 5.902
Salva come PNG Salva come JPEG
Nome #
Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. 74
Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. 73
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha. 72
Extraocular muscle antibodies positivity as the only serum marker of euthyroid Graves' ophthalmopathy following subacute thyroiditis: case report. 69
Graves' disease. 69
An improved polymerase chain reaction (PCR) protocol for unambigous detection of growth hormone gene deletions. 68
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects. 67
A Unique Patient Presenting with Concomitant Klinefelter Syndrome, Alport Syndrome and Craniopharyngioma. 66
An unusual therapeutic approach to a large thyroid nodule 65
Effect of Interferon-γ on the Basal and the TNF α-Stimulated Secretion of CXCL8 in Thyroid Cancer Cell Lines Bearing Either the RET/PTC Rearrangement or the BRAF V600e Mutation 64
Shear wave elastography in the diagnosis of thyroid nodules: feasibility in the case of coexistent chronic autoimmune Hashimoto's thyroiditis 63
TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer 63
THYREOTROPIN LEVELS IN DIABETIC PATIENTS ON METFORMIN TREATMENT. 62
Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. 61
Prevalence of Double Pituitary Adenomas in a Surgical Series: Clinical, Histological and Genetic Features. 61
Type I and type II interferons inhibit both basal and tumor necrosis factor-α-induced CXCL8 secretion in primary cultures of human thyrocytes. 61
Intraepidermal nerve fiber density reduction as a marker of preclinical asymptomatic small-fiber sensory neuropathy in hypothyroid patients. 60
Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy. 59
Low insulin resistance and preserved beta-cell function contribute to human longevity but are not associated with TH-INS genes. 59
A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. 59
Performance of the ACR TI-RADS and EU TI-RADS scoring systems in the diagnostic work-up of thyroid nodules in a real-life series using histology as reference standard 59
Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C. 58
Pretransplant Positivity for Circulating Thyroid Antibodies and Graft Survival in Patients Undergoing Kidney Transplant. 58
CXCL8 in thyroid disease: From basic notions to potential applications in clinical practice. 57
Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. 57
Impaired outcome of controlled ovarian hyperstimulation in women with thyroid autoimmune disease. 57
The AMPK-activator AICAR in thyroid cancer: effects on CXCL8 secretion and on CXCL8-induced neoplastic cell migration 57
Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections. 56
Elevated serum interferon-gamma-inducible chemokine-10/CXC chemokine ligand-10 in autoimmune primary adrenal insufficiency and in vitro expression in human adrenal cells primary cultures after stimulation with proinflammatory cytokines. 55
-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110. 55
Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper- or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. 54
A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells. 54
Graves'-like orbitopathy in a patient with chronic autoimmune pancreatitis. 54
Expanding the therapeutic spectrum of metformin: From diabetes to cancer 54
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate? 54
High pretransplant serum levels of CXCL10/IP-10 are related to increased risk of renal allograft failure. 53
Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. 53
The urokinase-plasminogen activator (PLAU) gene is not associated with late onset Alzheimer's disease. 53
Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study. 52
Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. 52
Metodo diagnostico per la previsione di rigetto di organo trapiantato 52
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 51
Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy. 51
Repeated laser thermal ablation of a large functioning thyroid nodule restores euthyroidism and ameliorates constrictive symptoms. 51
Risk of coronary heart disease and mortality for adults with subclinical hypothyroidism. 51
Toxic Diffuse Goiter (Basedow-Graves' Disease) 51
Body weight changes in a large cohort of patients subjected to thyroidectomy for a wide spectrum of thyroid diseases 51
Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. 50
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta. 50
Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: a prospective study. 50
Diabetes insipidus and increased serum levels of leptin and lactate-dehydrogenase (LDH) in an adolescent boy with a primary intracranial germinoma. Case report and an endocrinological revaluation of literature. 50
Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient's risk. 50
CB1 receptor antagonism/inverse agonism increases motor system excitability in humans. 50
Prenatal measurement of testicular diameter by ultrasonography: development of fetal male gender and evaluation of testicular descent. 49
Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis. 49
Thyroid and obesity: not a one-way interaction 49
Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association 49
Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. 48
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. 48
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. 48
Studying plasticity of sensory function: insight from pregnancy. 48
Multicenter study on TGPO autoantibody prevalence in various thyroid and non-thyroid diseases; relationships with thyroglobulin and thyroperoxidase autoantibody parameters. 48
Uso de antagonistas y/o agonistas inversos de los receptores CB1 para la preparacion de medicamentos que incrementen la excitabilidad de las motoneuronas 48
Compared with classic Hashimoto’s thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of l-thyroxine to correct hypothyroidism 48
Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. 48
Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves' ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. 47
Long-term treatment with interferon-beta therapy for multiple sclerosis and occurrence of Graves' disease. 47
Lack of association between changes in plasma leptin concentration and in food intake during the menstrual cycle. 47
Interferon-B but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: A clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugs 47
Autoimmune thyroid diseases in patients treated with alemtuzumab for multiple sclerosis: An example of selective anti-TSH-receptor immune response 47
Maximal stiffness evaluation by real-time ultrasound elastography, an improved tool for the differential diagnosis of thyroid nodules 47
Eight parathyroid glands incidentally discovered during a surgical intervention for secondary hyperparathyroidism: an unusual clinical finding. 46
Correlation between, clinical, biochemical, color Doppler ultrasound thyroid parameters, and CXCL-10 in autoimmune thyroid diseases. 46
The chemokine system as a therapeutic target in autoimmune thyroid diseases: a focus on the interferon-γ inducible chemokines and their receptor. 46
The Amh as a predictor of ovarian reserve and the role of thyroid autoimmunity in the protocols of assisted reproduction techniques 46
Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. 46
Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay 46
Unusual case of cervical pregnancy after curettage for a presumptive diagnosis of intrauterine blighted ovum. 45
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism. 45
Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence. 45
Low serum and peritoneal fluid concentration of interferon-gamma-induced protein-10 (CXCL10) in women with endometriosis. 45
Simultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's disease. 45
Etiopathogenesis of Basedow's disease. Trends and current aspects 45
Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: The hidden role of thyroid autoimmunity 45
Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. 45
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretion. 44
Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism. 44
Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. 43
A male patient with acromegaly and breast cancer: Treating acromegaly to control tumor progression 43
The influence of parity on multinodular goiter prevalence in areas with moderate iodine deficiency 42
Improvement of intra-epidermal nerve fiber density in hypothyroidism after L-thyroxine therapy. 42
Normal human thyroid cells, BCPAP, and TPC-1 thyroid tumor cell lines display different profile in both basal and TNF-α-induced CXCL8 secretion 42
Estrogen receptor alpha promoter polymorphism: stronger estrogen action is coupled with lower sperm count. 42
Perfluorooctane sulfonate and perfluorooctanoic acid in surgical thyroid specimens of patients with thyroid diseases. 42
Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. 41
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 41
Successful outcome of pregnancy in a thyroidectomized-parathyroidectomized young woman affected by severe hypothyroidism. 41
Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure. 41
Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) 41
GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES' DISEASE 41
Totale 5.183
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.930
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 5 2 9
2019/20201.952 608 819 2 78 6 89 59 88 3 137 59 4
2020/2021901 90 72 21 81 2 100 95 156 33 127 100 24
2021/2022797 18 8 3 26 24 27 15 57 50 7 140 422
2022/20232.763 290 148 68 241 260 270 0 153 1.211 16 74 32
2023/2024857 145 181 37 74 88 225 26 58 4 19 0 0
Totale 8.457